The daily foundation: Advanced Duo. The optional addition: Ruby Radiance.

THE ENDOLLS NOTEBOOK · ARCHIVE

Is There a Single Solution for Endometriosis and Adenomyosis?

April 18, 2026

This is an existing educational article from our archive. For the current product formulation and our evidence standards, consult the ingredient library and research room. Articles do not replace medical advice or establish that our products treat a disease.

Watch the original video on TikTok

Full transcript of the original video, lightly edited for readability.

What if the real reason so many women stay stuck with endometriosis is because they keep being sold one big hammer for a disease that behaves like a network? Because that is the real problem. Endometriosis is not one switch. It is not one receptor, it is not one cytokine, it is not one hormone. It is a wound. Like inflammatory, estrogen fed, immune, distorted, remodeling disease network. And when you deal with a network, the smartest strategy is not to worship one target. It is to keep pushing the most important connected pathways back toward homeostasis a little at a time.

That has been our framework from the start. Not top down hormone brute force, but bottom up pressure on the diseases foundations and prerequisites. That is why our formula was never built around the fantasy of one ingredient hitting one magic switch and the disease disappearing. It was built around pillars like cellular injury, inflammation, tissue remodeling, cellular proliferation. That is the logic, that is the architecture. And that is exactly why it makes more biological sense than pretending endometriosis is nothing more than too much estrogen or bad periods.

Now let's get more precise. ENDLES works by trying to nudge several known biochemical systems that are repeatedly implicated in endometriosis and adenomyosis. The reason this matters is simple. The literature already shows that these pathways are connected. PGE2 feeds estrogen production. Estrogen feeds lesion survival and growth. Platelets feed estrogen production and fibrogenesis. Progesterone Resistance removes a breaking system, and once that network is moving, the body drifts away from homeostasis. So pillar No. 1 is inflammation. If you want to understand why women with endometriosis hurt, why they bloat, why the pelvis feels chemically inflamed, you have to understand the COX-2 and prostaglandin side of this disease.

COX-2 is overexpressed prostaglandin signaling rises. And PGE2 does not just create pain, it also feeds steroidogenesis, angiogenesis, matrix remodeling, and the positive feedback loop that keeps lesions biologically active. That is why reducing inflammatory pressure is not just about making somebody more comfortable. It is about trying to calm one of the engines that keeps the system moving. And that is also why the literature on anti inflammatory lipid balance matters. When Omega 3 pressure is increased in animal models, lesion burden and inflammatory mediators move in the right direction.

Pillar No. 2 is local estrogen biosynthesis and receptor bias. This is where a lot of people oversimplify the disease. The question is not just is there estrogen? The question is what is the lesion doing with estrogen? Locally in endometriosis there is increased aromatase activity, decreased 17 beta H S D 2, greater bioavailability of estrogen, and a disturbed balance between estrogen action and progesterone action. Estrogen supports lesion survival, inflammation, and proliferation. That is a huge part of why simply suppressing the entire system from above often fails long term.

And now add platelets, Into that picture, activated platelets do not just show up because tissue bleeds. They actively worsen the feed forward loop. They can increase estrogen production through upregulation of aromatase. They also activate NF-kappa B and TGF-beta 1 pathways and further push the lesion into an estrogen producing, wound like self reinforcing state. We look at it as part of a wound inflammation platelet growth network. Pillar No. 3 is oxidative stress and detoxification pressure. Oxidative stress is repeatedly implicated in endometriosis.

Patients tend to have reduced antioxidant capacity. A multi center clinical trial using an antioxidant combination reported improvement in pain. The framework is the same. When you reduce oxidative stress upstream, women can feel the difference. Pillar No. 4 is wound behavior, platelet behavior, coagulation pressure, and tissue remodeling. Endometriotic lesions behave like wounds undergoing repeated tissue injury and repair. That is not a metaphor. Platelets contribute to progression and hypercoagulability. The disease is not just sitting there causing pain. It is altering systemic wound and coagulation behavior.

Okay, so how do we target all of this? Well, let's take a look at one of the extracts that you will find in our supplement. This example will highlight the concept behind each extract, specifically the biomolecules inside them. 3 3 diindolyl methane, commonly known as DIM. First, DIM is discussed as an antioxidant compound derived from indole 3 carbon that can influence estrogen activity in cells by inhibiting the estrogen receptor. In this model, DIM, Is treated as a ligand or a key that could bias ER-beta toward active state occupancy.

The receptor moves stochastically through four states, and the probability shifts according to the equilibrium function. In simpler terms, we are using this compound due to the interaction it has with the receptor, continually pushing towards a specific activation state. Why is that important? Because active state occupancy is a gate into downstream signaling and transcription. In other words, receptor state behavior is not just abstract math. It is the doorway into biological consequence. And in endometriosis, estrogen receptor beta is not a background detail.

Increased estrogen can further induce estrogen receptor beta. Estrogen receptor beta feeds more COX-2 activity, and that helps perpetuate the inflammatory PGE2 rich feed forward loop that keeps lesions biologically active. So if you can bias receptor state occupancy inside a network like that, you are not just changing a receptor, you are potentially changing pressure inside the loop itself. That is exactly how we think about ENDOLLS. Not as a singular kill shot, as continual pushback, as repeated bias, as network pressure, as sarcastic steering toward homeostasis.

So when we use a formula designed to lean against these loops at the same time, the idea is network topology. You identify highly connected nodes and push several of them at once. And that is also why this approach is more honest. I am not telling women. Take this and we will Cure endometriosis. I am telling them something much more rigorous. We know this disease is estrogen dependent. Prostaglandins matter, platelets matter. So how does ENDOLLS work? It works by using a model that scales up from one receptor to many receptors in a cell.

Now you are no longer asking what one receptor is doing. You are asking what fraction of the whole receptor population is active. At that level, the system still does not behave like a clean switch. It has drift and it has noise. The drift pulls the system toward a new equilibrium, while the noise keeps fluctuations alive. That is exactly why this matters for the bigger end dolls concept. A living system does not stay fixed after one shove. It fluctuates, it drifts, it resists.

Which means pushing the body toward homeostasis is not a one touch event. It is a process of repeated directional bias. Repeated push back, repeated pressure on the right nodes. Long enough for the system to spend more time in healthier territory than pathological territory. That is the mathematical logic behind why continual pushback matters. That is why ENDOLLS is a system's biology supplement. If you want an in depth explanation of how stochastic process and network topology can be applied for real change, comment explanation below.

A MORE CONSIDERED ROUTINE

Clarity first.
Then your next step.